Mianserin--a new tetracyclic antidepressant. 1979

M Fink

UI MeSH Term Description Entries
D008803 Mianserin A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors. Lerivon,Mianserin Hydrochloride,Mianserin Monohydrochloride,Org GB 94,Tolvon,Hydrochloride, Mianserin,Monohydrochloride, Mianserin
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D003984 Dibenzazepines Compounds with two BENZENE rings fused to AZEPINES.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Fink
January 1978, Folia psychiatrica et neurologica japonica,
M Fink
April 1983, Postgraduate medical journal,
M Fink
July 2008, Naunyn-Schmiedeberg's archives of pharmacology,
M Fink
December 1998, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,
M Fink
August 2001, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!